Table 2.
56 identified potential biomarkers among the WKY, SHR and test compounds.
| No | Fragment | tR(min) | m/z | Change | Biomarkers | |||
|---|---|---|---|---|---|---|---|---|
| aSHR | bUET | bRT | bIT | |||||
| 1 | [M−H]− | 9.46 | 315.25430 | ↓ | ↑ | ↑ | MG(15:0) | |
| 2 | [M+H]+ | 12.57 | 595.52951 | ↑ | DG(34:1) | |||
| 3 | [M+H]+ | 11.23 | 593.51672 | ↑ | ↓ | DG(34:2) | ||
| 4 | [M+H]+ | 11.23 | 611.54452 | ↑ | ↓ | ↓ | DG(35:0) | |
| 5 | [M+H]+ | 9.22 | 607.51278 | ↑ | ↓ | DG(35:2) | ||
| 6 | [M+H]+ | 11.30 | 621.53383 | ↑ | DG(36:2) | |||
| 7 | [M+H]+ | 11.31 | 619.53112 | ↑ | DG(36:3) | |||
| 8 | [M+H]+ | 10.20 | 617.51453 | ↑ | ↓ | DG(36:4) | ||
| 9 | [M+H]+ | 10.20 | 635.54441 | ↑ | ↓ | ↓ | DG(37:2) | |
| 10 | [M+H]+ | 21.09 | 819.72638 | ↑ | TG(49:1) | |||
| 11 | [M+H]+ | 21.14 | 845.74194 | ↑ | TG(51:2) | |||
| 12 | [M+H]+ | 21.28 | 859.75805 | ↑ | ↓ | TG (52:2) | ||
| 13 | [M+H]+ | 21.42 | 855.74175 | ↑ | TG (52:4) | |||
| 14 | [M+H]+ | 20.94 | 873.69390 | ↑ | TG (54:9) | |||
| 15 | [M+H]+ | 20.83 | 893.74210 | ↑ | ↓ | ↓ | TG (55:6) | |
| 16 | [M+H]+ | 21.65 | 919.85124 | ↑ | TG (56:0) | |||
| 17 | [M+H]+ | 20.51 | 897.69435 | ↑ | ↓ | ↓ | TG (56:11) | |
| 18 | [M+H]+ | 21.41 | 911.78964 | ↑ | ↓ | ↓ | TG (56:4) | |
| 19 | [M+H]+ | 21.25 | 941.83068 | ↑ | ↓ | ↓ | TG (58:0) | |
| 20 | [M+H]+ | 20.07 | 921.69465 | ↑ | ↓ | ↓ | TG (58:13) | |
| 21 | [M−H]− | 3.41 | 423.27580 | ↓ | ↑ | LysoPA (18:0) | ||
| 22 | [M−H]− | 6.16 | 465.30469 | ↓ | ↑ | ↑ | ↑ | LysoPA (20:0) |
| 23 | [M+H]+ | 5.89 | 522.35524 | ↓ | LysoPC (18:1) | |||
| 24 | [M+H]+ | 5.37 | 520.33999 | ↓ | LysoPC (18:2) | |||
| 25 | [M+H]+ | 6.65 | 552.40265 | ↓ | LysoPC (20:0) | |||
| 26 | [M+H]+ | 5.33 | 546.34363 | ↓ | LysoPC (20:3) | |||
| 27 | [M+H]+ | 5.32 | 544.33956 | ↓ | LysoPC (20:4) | |||
| 28 | [M+H]+ | 6.65 | 578.41803 | ↓ | LysoPC (22:1) | |||
| 29 | [M+H]+ | 7.16 | 606.45261 | ↓ | ↑ | LysoPC (24:1) | ||
| 30 | [M-H]- | 5.01 | 480.30993 | ↓ | LysoPE (18:0) | |||
| 31 | [M+H]+ | 4.81 | 476.27854 | ↓ | ↑ | LysoPE (18:3) | ||
| 32 | [M+H]+ | 6.05 | 510.35628 | ↓ | LysoPE (20:0) | |||
| 33 | [M+H]+ | 4.59 | 498.26282 | ↓ | ↑ | LysoPE (20:5) | ||
| 34 | [M-H]- | 16.07 | 661.50530 | ↑ | ↓ | ↓ | ↓ | PA (34:0) |
| 35 | [M+H]+ | 12.95 | 832.66404 | ↓ | ↑ | PE (32:0) | ||
| 36 | [M+H]+ | 8.59 | 702.50617 | ↓ | PE (33:2) | |||
| 37 | [M+H]+ | 10.24 | 802.62359 | ↓ | PE (40:1) | |||
| 38 | [M+H]+ | 10.24 | 800.61666 | ↓ | PE (40:2) | |||
| 39 | [M+H]+ | 15.32 | 856.68942 | ↓ | ↑ | ↑ | PE (44:1) | |
| 40 | [M+H]+ | 6.61 | 815.48703 | ↑ | PG (40:9) | |||
| 41 | [M+H]+ | 7.22 | 799.56799 | ↑ | PG (38:4) | |||
| 42 | [M+H]+ | 6.65 | 821.52288 | ↑ | PG (40:7) | |||
| 43 | [M+H]+ | 6.60 | 863.55928 | ↑ | PI (36:2) | |||
| 44 | [M+H]+ | 6.59 | 840.57451 | ↑ | ↓ | PS (40:4) | ||
| 45 | [M+H]+ | 10.27 | 677.56590 | ↑ | ↓ | ↓ | SM (d18:0/14:0) | |
| 46 | [M−H]− | 12.68 | 298.28348 | ↓ | Sphingosine | |||
| 47 | [M−H]− | 4.34 | 277.21738 | ↓ | ↑ | ↑ | ↑ | α-linolenic acid |
| 48 | [M−H]− | 12.21 | 335.29599 | ↓ | Docosadienoate (22:2) | |||
| 49 | [M−H]− | 2.12 | 299.25947 | ↑ | Hydroxystearic acid | |||
| 50 | [M−H]− | 16.10 | 279.23315 | ↑ | ↓ | ↓ | Linoleic acid | |
| 51 | [M−H]− | 0.51 | 181.03348 | ↑ | Methyluric acid | |||
| 52 | [M−H]− | 12.67 | 297.28013 | ↓ | Pristanic acid | |||
| 53 | [M−H]− | 6.67 | 355.26473 | ↓ | Tetracosahexaenoic acid | |||
| 54 | [M−H]− | 9.87 | 296.26777 | ↓ | Palmitoleoyl Ethanolamide | |||
| 55 | [M−H]− | 11.7 | 593.54197 | ↓ | ↑ | CE(14:1) | ||
| 56 | [M−H]− | 0.52 | 259.02717 | ↑ | ↓ | Glucose 1-phosphate | ||
(↑): upregulated (p < 0.05, n = 8), (↑): downregulated (p < 0.05, n = 8).
aTrends of the SHR group compared with the WKY group of metabolites. bTrends of the vtest compounds compared with the SHR group of metabolites.